Patient/Sample-No. | A | B | C | D | E | F | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Spot-No. | Protein | #02-05p | #02-02b | #02-06p | #02-03b | #02-24p | #02-25b | #02-33p | #02-34b | #02-37p | #02-36b | #02-39p | #02-38b |
5 | 14-3-3 related | + | + | ||||||||||
19 | Annexin 6, Calectrin (67 kDa) | + | + | + | + | + | + | + | + | + | + | ||
60 | FK506 binding protein 4 | + | + | + | + | + | + | + | + | + | + | ||
91 | Ku antigen (86 kDa) | + | + | + | + | + | + | + | + | + | + | ||
102 | Phosphoglyceromutase | + | + | + | + | + | + | + | + | + | + | + | |
103 | Plasminogen activator inhibitor-2 | + | + | + | + | ||||||||
104 | Plasminogen activa. inhib.-2 var. | + | + | + | + | ||||||||
115 | Rho A | * | * | + | + | + | + | + | + | + | + | ||
121 | TCHTP | * | * | + | + | ||||||||
122 | TCHTP var. | * | * | + | + | ||||||||
130 | Vimentin | + | + | + | + | + | + | + | + | + | + | + |